Drug Research

The market when it comes to connected drug delivery devices is going through rapid growth, with an expected annual market growth rate of more than 20% between 2023 and 2030. This progress is driven, in part, by the increasing...

The National Pharmaceutical Regulatory Agency- NPRA of Malaysia has recently gone on to revise its guidelines with regards to the approval pathways for medicines that have already been authorized in certain overseas territories. The changes made by NPRA go on...

Market-leading commercialization platform, Inizio, has announced ‘Inizio Launch Elevate’, a connected suite of its best-in-class capabilities designed to accelerate and simplify product launches for global pharma and biotech companies. Inizio Launch Elevate combines deep market and patient insights, launch strategy...

Greenphire, the global leader in patient convenience and financial lifecycle management for clinical trials, and Florence Healthcare, the leading site enablement platform used by 18,000 connected research sites in 55 countries, announce a technology partnership that integrates two of...

Charles River Laboratories International, Inc.  and Aitia, a leader in the application of Causal AI and Digital Twins announced a strategic agreement that gives Aitia access to Logica™, Charles River's Artificial Intelligence (AI) powered drug solution platform, for the...

Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions announced that it has entered into a strategic collaboration with GeneQuantum Healthcare to advance the early discovery of next-generation bioconjugates. Under the terms of the collaboration,...

Legend Biotech has secured an exclusive global license deal with Novartis giving the Swiss pharma access to Legend’s CAR-T cell therapies. The deal will give Novartis access to CAR-Ts that target the delta-like ligand protein (DLL3) candidate LB2102, which Legend...